{
    "2021-02-18": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Why Rigel Pharmaceuticals Stock Is Jumping Today",
                "features": {
                    "keywords": [
                        "Rigel Pharmaceuticals",
                        "Stock",
                        "Jumping"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Return On Capital Employed Overview: Eli Lilly",
                "features": {
                    "keywords": [
                        "Return",
                        "Capital",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Licensing Deal",
                        "vTv",
                        "Psoriasis",
                        "Immunic"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "UPDATE 1-Eli Lilly in deal with Rigel to develop autoimmune therapy for up to $960 mln",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Rigel",
                        "Autoimmune Therapy",
                        "$960 mln"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Rigel Pharma shares soar 39% premarket on news of deal with Eli Lilly",
                "features": {
                    "keywords": [
                        "Rigel Pharma",
                        "Shares",
                        "Soar",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Rigel",
                        "Strategic Collaboration",
                        "RIPK1 Inhibitors"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Rigel Pharmaceuticals Rises on Drug Venture With Eli Lilly",
                "features": {
                    "keywords": [
                        "Rigel Pharmaceuticals",
                        "Rises",
                        "Drug Venture",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Rigel Higher on Immunology-Drug Venture With Eli Lilly",
                "features": {
                    "keywords": [
                        "Rigel",
                        "Higher",
                        "Immunology-Drug",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}